This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Protection against reactive oxygen species in neurodegeneration Investments > €500k European Commission Motor neurone diseases 2016
Protein Misfolding: Prion-like Propagation and Cure. Implications for Neurodegenerative Diseases. Investments > €500k European Commission Neurodegenerative disease in general 2016
The Molecular Communication Mechanism of Motor Neuron Survival and Synapse Maintenance Investments > €500k European Commission Motor neurone diseases 2016
The Role of Non-coding RNA in Protein Networks and Neurodegenerative Diseases Investments > €500k European Commission Neurodegenerative disease in general 2016
European Medical Information Framework (EMIF) Investments > €500k European Commission Alzheimer’s disease & other dementias 2016
Simulation of the Kinetics and Inverse Problemfor the Protein PolymERizationin Amyloid Diseases (Prion, Alzheimer’s) Investments > €500k European Commission Alzheimer’s disease & other dementias|Prion disease 2016
Gene therapy and nanotechnology based CNS targeted vectors Investments > €500k European Commission Motor neurone diseases|Spinal muscular atrophy (SMA) 2016
Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy Investments > €500k European Commission Parkinson’s disease & PD-related disorders 2016
European stem cell consortium for neural cell replacement, reprogramming and functional brain repair Investments > €500k European Commission Huntington’s disease|Parkinson’s disease & PD-related disorders 2016
Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntingtons disease Investments > €500k European Commission Huntington’s disease|Parkinson’s disease & PD-related disorders 2016
